GOLD 2023: What’s New, Doc?
marzo 1, 2023
This issue of Archivos de Bronconeumología features an executive summary of the new 2023.
This issue of Archivos de Bronconeumología features an executive summary of the new 2023.
«Chronic airway diseases such as asthma and chronic obstructive pulmonary disease are prevalent and complex conditions that often coexist in the same patient. To address this complexity in clinical practice, and to move forward toward personalized and precision…»
Patients with COPD can have acute episodes of worsening symptoms, known generically as exacerbations, which are clinically relevant because they involve an acute deterioration of the patient’s health status, worsen the patient’s prognosis, and are the main cause of economic expenditure associated with COPD.
«Chronic airway diseases such as asthma and chronic obstructive pulmonary disease are prevalent and complex conditions that often coexist in the same patient. To address this complexity in clinical practice, and to move forward toward personalized and precision…»
It is now well established that there is a range of lung function tralectories throughout the life course.
Approximately 25% and 65% of patients hospitalized for an ECOPD die within 1 and 5 years, respectively.
Exposure to air pollution is a major contributor to the pathogenesis of chronic obstructive pulmonary disease (COPD) worldwide.
The European Respiratory Journal is voluntarily reviewed. We are most grateful for the hard work and dedication of all those who reviewed articles for the ERJ in 2022.
In conclusion, these observations show, for the first time to our knowledge, that being born SGA at term tracks into a shorter height in early adulthood but does not result in reduced lung function for that reduced height.
«Chronic airway diseases such as asthma and chronic obstructive pulmonary disease are prevalent and complex conditions that often coexist in the same patient. To address this complexity in clinical practice, and to move forward toward personalized and precision…»